The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, ...
Answers Pet Food and Darwin’s Natural Pet Products, were found to have produced pet food that was contaminated with the ...
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and ...
Cobenfy targets cholinergic receptors instead of the dopamine receptors long addressed in current schizophrenia drugs — a new treatment approach to the disease.
Bristol Myers Squibb shares rose Friday, a day after its schizophrenia drug was approved for use by the Food and Drug Administration.
Dupixent is the first biologic medicine approved in the U.S. for the common lung condition, though competitors from GSK, AstraZeneca and Roche could follow.
The U.S. Food and Drug Administration (FDA) has recalled a number of dog food products after they were found to be contaminated with harmful bacteria. The FDA recommends that these products should ...
Her expertise is in personal finance and investing, and real estate. The Food and Drug Administration (FDA) is a government agency that is responsible for the promotion and protection of public ...
The Food and Drug Administration announced Friday it had ... flexibility and accessibility," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in a statement.
Over the last 34 years, Barbara Cassens, Director of Office of Partnerships at U.S. Food and Drug Administration, has made ...